Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Access Group was a leading U.S.-based healthcare communications, consulting, market access, and commercialization services firm serving pharmaceutical, biotechnology, and medical device companies. It provided strategic brand solutions throughout the product lifecycle—from prelaunch to loss of exclusivity—helping clients navigate complex reimbursement environments with expertise in health economics/outcomes research (HEOR), managed markets strategy, promotional branding, analytics, patient support programs, pricing/reimbursement strategy consulting. In recent years it was acquired by EVERSANA—a global leader in integrated commercial services for life sciences—combining its offerings into an expanded platform focused on value demonstration and patient-centric commercialization
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Access Group.